Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities.

Jardim DL, Conley A, Subbiah V.

Orphanet J Rare Dis. 2013 Jul 30;8:112. doi: 10.1186/1750-1172-8-112.

PMID:
23895135
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Phyllodes tumors of the breast segregate in two groups according to genetic criteria.

Laé M, Vincent-Salomon A, Savignoni A, Huon I, Fréneaux P, Sigal-Zafrani B, Aurias A, Sastre-Garau X, Couturier J.

Mod Pathol. 2007 Apr;20(4):435-44. Epub 2007 Mar 2.

PMID:
17334353
[PubMed - indexed for MEDLINE]
Free Article
3.

Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression.

Ang MK, Ooi AS, Thike AA, Tan P, Zhang Z, Dykema K, Furge K, Teh BT, Tan PH.

Breast Cancer Res Treat. 2011 Sep;129(2):319-29. doi: 10.1007/s10549-010-1204-5. Epub 2010 Oct 14.

PMID:
20945089
[PubMed - indexed for MEDLINE]
4.

Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours.

Kuijper A, Snijders AM, Berns EM, Kuenen-Boumeester V, van der Wall E, Albertson DG, van Diest PJ.

Cell Oncol. 2009;31(1):31-9.

PMID:
19096148
[PubMed - indexed for MEDLINE]
5.

Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression.

Kersting C, Kuijper A, Schmidt H, Packeisen J, Liedtke C, Tidow N, Gustmann C, Hinrichs B, Wülfing P, Tio J, Boecker W, van Diest P, Brandt B, Buerger H.

Lab Invest. 2006 Jan;86(1):54-61.

PMID:
16258523
[PubMed - indexed for MEDLINE]
Free Article
6.

Theranostic Profiling for Actionable Aberrations in Advanced High Risk Osteosarcoma with Aggressive Biology Reveals High Molecular Diversity: The Human Fingerprint Hypothesis.

Egas-Bejar D, Anderson PM, Agarwal R, Corrales-Medina F, Devarajan E, Huh WW, Brown RE, Subbiah V.

Oncoscience. 2014 Mar 12;1(2):167-179.

PMID:
25126591
[PubMed]
Free PMC Article
7.

Loss of SDHB and NF1 genes in a malignant phyllodes tumor of the breast as detected by oligo-array comparative genomic hybridization.

Lee J, Wang J, Torbenson M, Lu Y, Liu QZ, Li S.

Cancer Genet Cytogenet. 2010 Jan 15;196(2):179-83. doi: 10.1016/j.cancergencyto.2009.09.005.

PMID:
20082856
[PubMed - indexed for MEDLINE]
8.
9.

Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate.

Wang X, Jones TD, Zhang S, Eble JN, Bostwick DG, Qian J, Lopez-Beltran A, Montironi R, Harris JJ, Cheng L.

Mod Pathol. 2007 Feb;20(2):175-82. Epub 2006 Dec 22.

PMID:
17192792
[PubMed - indexed for MEDLINE]
Free Article
10.

Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study.

Lv S, Niu Y, Wei L, Liu Q, Wang X, Chen Y.

Breast Cancer Res Treat. 2008 Dec;112(3):411-8. doi: 10.1007/s10549-007-9876-1. Epub 2008 Jan 13.

PMID:
18189161
[PubMed - indexed for MEDLINE]
11.

The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome.

Przybytkowski E, Ferrario C, Basik M.

BMC Med Genomics. 2011 Jan 27;4:16. doi: 10.1186/1755-8794-4-16.

PMID:
21272361
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].

Lázár V.

Magy Onkol. 2013 Jun;57(2):96-9. doi: MagyOnkol.2013.57.2.96. Epub 2013 May 20. Hungarian.

PMID:
23795354
[PubMed - indexed for MEDLINE]
Free Article
13.

Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein.

Subbiah V, Westin SN, Wang K, Araujo D, Wang WL, Miller VA, Ross JS, Stephens PJ, Palmer GA, Ali SM.

J Hematol Oncol. 2014 Jan 14;7(1):8. doi: 10.1186/1756-8722-7-8.

PMID:
24422672
[PubMed - in process]
Free PMC Article
14.

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

André F, Bachelot T, Commo F, Campone M, Arnedos M, Dieras V, Lacroix-Triki M, Lacroix L, Cohen P, Gentien D, Adélaide J, Dalenc F, Goncalves A, Levy C, Ferrero JM, Bonneterre J, Lefeuvre C, Jimenez M, Filleron T, Bonnefoi H.

Lancet Oncol. 2014 Mar;15(3):267-74. doi: 10.1016/S1470-2045(13)70611-9. Epub 2014 Feb 7.

PMID:
24508104
[PubMed - indexed for MEDLINE]
15.

A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.

Vasan N, Yelensky R, Wang K, Moulder S, Dzimitrowicz H, Avritscher R, Wang B, Wu Y, Cronin MT, Palmer G, Symmans WF, Miller VA, Stephens P, Pusztai L.

Oncologist. 2014 May;19(5):453-8. doi: 10.1634/theoncologist.2013-0377. Epub 2014 Apr 7.

PMID:
24710307
[PubMed - in process]
16.

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.

Holstege H, Horlings HM, Velds A, Langerød A, Børresen-Dale AL, van de Vijver MJ, Nederlof PM, Jonkers J.

BMC Cancer. 2010 Nov 30;10:654. doi: 10.1186/1471-2407-10-654.

PMID:
21118481
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Osteosarcomatous differentiation in lung metastases from a malignant phyllodes tumour of the breast.

Tsubochi H, Sato N, Kaimori M, Imai T.

J Clin Pathol. 2004 Apr;57(4):432-4. Review.

PMID:
15047752
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.

Jones AM, Mitter R, Springall R, Graham T, Winter E, Gillett C, Hanby AM, Tomlinson IP, Sawyer EJ; Phyllodes Tumour Consortium.

J Pathol. 2008 Apr;214(5):533-44. doi: 10.1002/path.2320.

PMID:
18288784
[PubMed - indexed for MEDLINE]
19.

Recent insights into the molecular pathogenesis of mammary phyllodes tumours.

Karim RZ, O'Toole SA, Scolyer RA, Cooper CL, Chan B, Selinger C, Yu B, Carmalt H, Mak C, Tse GM, Tan PH, Putti TC, Lee CS.

J Clin Pathol. 2013 Jun;66(6):496-505. doi: 10.1136/jclinpath-2012-201082. Epub 2013 Feb 12. Review.

PMID:
23404800
[PubMed - indexed for MEDLINE]
20.

Immunohistochemical and molecular markers in breast phyllodes tumors.

Korcheva VB, Levine J, Beadling C, Warrick A, Countryman G, Olson NR, Heinrich MC, Corless CL, Troxell ML.

Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):119-25. doi: 10.1097/PAI.0b013e3181f5349a.

PMID:
21030860
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk